Walgreens Q2 Sales Surge

Walgreens Boots Alliance Inc. has announced a notable 3.9% increase in total sales for the second quarter of fiscal 2025, reaching an impressive $38.6 billion. This performance not only surpasses the figures from the same period last year but also exceeds analysts' expectations.

Financial Highlights

The company reported a reduced net loss of $4 billion, a significant improvement from the $12.3 billion loss recorded in the second quarter of 2024. Similarly, the net loss per diluted share decreased to $3.30 from $6.85 a year ago.

Strategic Insights

"Our second-quarter results demonstrate effective cost management and progress in U.S. Healthcare, despite challenges in U.S. Retail Pharmacy front-end performance. The impact of major legal settlements has affected our free cash flow. We are at the beginning of our strategic turnaround, and while we anticipate that creating substantial value will require time, we are committed to this journey," stated CEO Tim Wentworth.

Following the earnings announcement, Walgreens' stock experienced a 1.96% increase in premarket trading.